In: The International Journal of Cardiovascular Imaging, 2015, vol. 31, no. 5, p. 915-926
|
In: European Radiology, 2015, vol. 25, no. 6, p. 1684-1691
|
In: Cell reports, 2017, vol. 18, no. 2, p. 496-507
The Mre11 complex (Mre11, Rad50, and Nbs1) is integral to both DNA repair and ataxia telangiectasia mutated (ATM)-dependent DNA damage signaling. All three Mre11 complex components are essential for viability at the cellular and organismal levels. To delineate essential and non-essential Mre11 complex functions that are mediated by Nbs1, we used TALEN-based genome editing to derive Nbs1...
|
In: Catheterization and Cardiovascular Interventions, 2019, p. ccd.28376
To evaluate the safety and efficacy outcomes after primary percutaneous coronary intervention (pPCI) with second‐generation Resolute™ zotarolimus‐eluting stent (R‐ ZES) in patients enrolled in the DAPT‐STEMI Trial (NCT01459627).Background: R‐ ZES is one of the most used drug eluting stents worldwide. To date, the safety and efficacy data of this stent in setting of STEMI is...
|
In: Cardiovascular Revascularization Medicine, 2019, vol. 20, no. 7, p. 577–582
Background: The advent of bioresorbable vascular scaffolds (BVS) was considered as a potential improvement in percutaneous coronary intervention (PCI) after the groundbreaking development of drug eluting stents (DES). However, the clinical performance, long-term safety and efficacy of BVS in complex coronary lesions remain uncertain. COMPARE ABSORB, a multicenter, single blind, prospective ...
|
In: Internal and Emergency Medicine, 2014, vol. 9, no. 3, p. 335-339
|
In: Cardiovascular Drugs and Therapy, 2007, vol. 21, no. 5, p. 389-398
|
In: Cardiovascular Drugs and Therapy, 1997, vol. 10, no. 6, p. 717-725
|
In: The International Journal of Cardiovascular Imaging, 2010, vol. 26, no. 3, p. 333-344
|
In: Cardiovascular Drugs and Therapy, 2007, vol. 21, no. 2, p. 99-108
|